Amgen (NASDAQ:AMGN) rose over 1% after European health regulators conditionally ... Apple (NASDAQ: AAPL) was the most traded stock - as its iPhone 6s and 6s Plus phones become available around the globe to …
Proactive Investors UK · 9/26/2015
Wall Street shares
In-depth coverage >
Investors in Amgen Inc (NASD: AMGN) saw new options become available this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options chain for the new March 20th contracts and …
Forbes · 1/23/2015
Amgen (NASDAQ:AMGN)‘s stock had its “hold” rating reaffirmed by stock analysts at Sanford C. Bernstein in a research report issued to clients and investors on Wednesday, reports. In related news, Director Fred Hassan … · 9/4/2015
ZURICH (Reuters) - The U.S. Food and Drug Administration has accepted Novartis (VX:NOVN) unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's (O:AMGN) blockbuster Enbrel drug, the … · 10/2/2015
Novartis copycat product
The Profit Scanner powered by Recognia is currently bullish on IBB and has also identified three individual biotech stocks that are looking great for short-term, bullish trades ... Triangle suggests that AMGN stock’s prior uptrend will continue.
NASDAQ · 2/20/2015
But some managers say it was overdone and are already eyeing bargains such as Gilead Sciences Inc (GILD.O) and Amgen Inc (AMGN.O). The Nasdaq Biotechnology ... was listed in six hedge fund portfolios. The …
Reuters · BySinead Carew · 9/30/2015
hedge funds
Specifically, the iShares Nasdaq Biotechnology ETF (IBB 306.35, -19.87) is now down 6.0% with the likes of Amgen (AMGN 138.80, -4.71), Celgene (CELG 107.80, -6.08), Regeneron (REGN 485.28, -36.72), and Vertex Pharmaceuticals (VRTX 103.03, -8.08 ...
Briefing Live Market Analysis · 9/25/2015
Today, shares of Amgen (NASDAQ:AMGN) have crossed bearishly below their 10-day moving ... or 17.3% below the average consensus analyst price target of $180.76. The stock should find initial resistance at its 200-day moving average (MA) of $160.00 …
Financial News Network Online · ByAdrienne Chilton · 9/16/2015
The biotechnology sector can be a land of immense spoils and incredible heartbreak. It’s not uncommon to see small and midsized biotech companies swing wildly in each direction because of clinical trial data or a decision by the Food and Drug …
Amgen (AMGN) stock was up 2.5% in afternoon trading on the stock market today after the company presented five studies on its new cholesterol drug over the weekend. Results eased safety concerns raised earlier in the month. Competitors Regeneron …
Investors Business Daily · ByAmy Reeves · 3/31/2014


AMGen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Locate…
AMGen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, AMGen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Data from: Wikipedia